论文部分内容阅读
1987年虽然化工原料供虚紧张,价格上涨,国际市场产品竞争激烈,但上海第二制药厂在向外向型转轨的道路上,又迈出了可喜的一步。1987年出口创汇比上一年增加40%以上,达1500万美元。除产品出口外,技术输出也取得新的成绩,继1986年以550万美元的价格向瑞士的岁氏公司转让维生素C二步发酵新工艺后,1987年向罗马尼亚转让磺胺嘧啶工艺技术又获得初步成功。这些成绩的取得,主要是因为该厂重视信息的运用,重视与国外的技术交流,重视新产品的开发。
In 1987, despite the intense supply of chemical raw materials and rising prices, the products in the international market were fiercely competitive, but the Shanghai No. 2 Pharmaceutical Factory took a promising step on the outward-oriented transition. In 1987, export earnings increased by more than 40% from the previous year to $15 million. In addition to product exports, technical output has also achieved new results. Following the transfer of a two-step fermentation process of vitamin C to Swiss Aged companies in 1986, the transfer of sulfadiazine technology to Romania in 1987 was preliminary. success. These achievements are mainly due to the fact that the plant attaches great importance to the use of information, attaches importance to foreign technical exchanges, and attaches importance to the development of new products.